Eberhard Grube, MD: Percutaneous heart valves

Eberhard Grube, MD, Chief of Cardiology at the Seigburg Heart center in Germany, discusses the new technology of percutaneous heart valves.

Eberhard Grube, MD: negative late loss with drug eluting stents

Eberhard Grube, MD, Chief of Cardiology at the Seigburg Heart center in Germany, discusses the problems of negative late loss caused by drug eluting stents with a durable polymer coating (Taxus, Cypher).

Question: Do you believe the new Xience, Promus or Endeavor stents also cause malaposition? Is Plavix, prasugrel (Effient) or other anticoagulation still required with the next-generation DES? Post your comments.